Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 16.6
1.41 %
$ 766 M
Market Cap
-8.38
P/E
Price Target
Average
73.69%
Revenue Forecast
Estimate
3.67%
EBIT
Estimate
0.89%
Net Income
Estimate
53.55%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Pacira BioSciences, Inc.
Wall Street analysts predict an average 1-year price target for PCRX of $28.8 , with forecasts ranging from a low of $8 to a high of $57 .
PCRX Lowest Price Target
Wall Street Target
8 USD
-51.81%
PCRX Average Price Target
Wall Street Target
28.8 USD
73.69%
PCRX Highest Price Target
Wall Street Target
57 USD
243.37%
REVENUE FORECAST
Revenue Forecast Chart PCRX
EBIT FORECAST
EBIT Forecast Chart PCRX
NET INCOME FORECAST
Net Income Chart PCRX